|
|||||
|
|
Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (rituximab). |
|
| Authors: | Yukinori Nakagawa Uichi Ikeda Masahiro Hirose Satoshi Ubukata Taka-Aki Katsuki Yuichiro Kaminishi Tsutomu Saito Mitsugu Hironaka Tohru Izumi Kazuyuki Shimada |
| Institution: | Division of Cardiovascular Medicine, Jichi Medical School, Tochigi, Japan. |
| Abstract: | Primary cardiac malignant lymphoma is extremely rare and almost all patients die within weeks. Monoclonal CD20 antibody (rituximab) was administered to a patient with primary cardiac B-cell non-Hodgkin's lymphoma expressing a CD20 molecule. The results suggest that rituximab may be a safe and effective new therapy for primary cardiac B-cell lymphoma. |
| Keywords: | |